Translating Proteomics Episode 8 – Expanding the Druggable Universe with Proteomics

‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery, drug development, food and energy security, and a range of other timely topics. The goal of these conversations is to expose you to important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.

Your hosts are Drs. Parag Mallick and Andreas Huhmer of Nautilus Biotechnology. Parag is an Associate Professor at Stanford University whose lab performs systems biology studies that drive precision medicine approaches for cancer diagnosis and treatment. Andreas is a veteran scientist whose industry work has supported thousands of proteomics researchers by helping to bring the latest mass spec technologies into their labs.

All Translating Proteomics episode links

Ep 1 – Poised for a Proteomics Breakthrough
Ep 2 – Putting Proteomics to Work
Ep 3 – Biology in Space and Time
Ep 4 – Single-protein Biomarkers Don’t Cut It
Ep 5 – Why the Dogma around Biology’s Central Dogma Is Wrong
Ep 6 – The Future of AI in Biomedicine
Ep 7 – Harnessing Proteoforms to Understand Life’s Complexity
Ep 8 – Expanding the Druggable Universe with Proteomics (You’re here)

Subscribe to Translating Proteomics on YouTube, Apple Podcasts, Spotify, or subscribe to our Translating Proteomics Newsletter to get the latest episodes delivered straight to your inbox.

Episode 8 – Expanding the Druggable Universe with Proteomics

Despite incredible leaps in our understanding of molecular biology, the majority of drug development efforts still fail, and those that succeed often fail to return investment dollars. Proteomics has the potential to change that by providing high-resolution views of the biochemical drivers of biological function – proteins. In this episode of Translating Proteomics, Parag and Andreas discuss how proteomics can help researchers identify good drug targets, personalize drug development, and advance precision medicine.

Chapters:

00:00 – How do we define good drug targets and “druggable” in the age of proteomics
08:16 – Advancing personalized medicine through proteomics
10:58 – How proteomics technologies have changed drug development
15:13 – New abilities next-generation proteomics technologies give us in drug development

Some key points of discussion:

• What makes a good drug target
• How we can better personalize drug development
• How proteomics has and will change drug development

Subscribe to the Translating Proteomics podcast on YouTube, Apple Podcasts, Spotify, or your favorite podcast outlet